These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30672598)

  • 1. Small Dense Low-Density Lipoprotein Cholesterol Predicts Cardiovascular Events in Liver Transplant Recipients.
    Siddiqui MB; Arshad T; Patel S; Lee E; Albhaisi S; Sanyal AJ; Stravitz RT; Driscoll C; Sterling RK; Reichman T; Bhati C; Siddiqui MS
    Hepatology; 2019 Jul; 70(1):98-107. PubMed ID: 30672598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.
    Duran EK; Aday AW; Cook NR; Buring JE; Ridker PM; Pradhan AD
    J Am Coll Cardiol; 2020 May; 75(17):2122-2135. PubMed ID: 32354380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients.
    Idowu MO; Chhatrala R; Siddiqui MB; Driscoll C; Stravitz RT; Sanyal AJ; Bhati C; Sargeant C; Luketic VA; Sterling RK; Contos M; Matherly S; Puri P; Siddiqui MS
    Liver Transpl; 2015 Nov; 21(11):1395-402. PubMed ID: 26228654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers.
    Chhatrala R; Siddiqui MB; Stravitz RT; Driscoll C; Sanyal A; Sargeant C; Luketic V; Sharma A; Sterling R; Matherly S; Puri P; Siddiqui MS
    Liver Transpl; 2015 May; 21(5):623-30. PubMed ID: 25762084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Relationship Between Hypoadiponectinemia and Cardiovascular Events in Liver Transplant Recipients.
    Siddiqui MB; Patel S; Arshad T; Lee E; Albhaisi S; Driscoll C; Wolver S; Reichman T; Bhati C; Siddiqui MS
    Transplantation; 2019 Nov; 103(11):2323-2328. PubMed ID: 30946215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small Dense Low Density Lipoprotein Cholesterol, Paraoxonase 1 and Lipid Profile in Postmenopausal Women: Quality or Quantity?
    Mogarekar MR; Kulkarni SK
    Arch Med Res; 2015 Oct; 46(7):534-8. PubMed ID: 26348135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial.
    Albers JJ; Slee A; Fleg JL; O'Brien KD; Marcovina SM
    Atherosclerosis; 2016 Aug; 251():454-459. PubMed ID: 27320173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
    Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
    Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small dense low-density lipoprotein cholesterol was associated with future cardiovascular events in chronic kidney disease patients.
    Shen H; Xu Y; Lu J; Ma C; Zhou Y; Li Q; Chen X; Zhu A; Shen G
    BMC Nephrol; 2016 Oct; 17(1):143. PubMed ID: 27716087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of Small Dense Low-Density Lipoprotein Cholesterol and Coronary Heart Disease in Subjects at High Cardiovascular Risk.
    Higashioka M; Sakata S; Honda T; Hata J; Shibata M; Yoshida D; Goto K; Kitazono T; Osawa H; Ninomiya T
    J Atheroscler Thromb; 2021 Jan; 28(1):79-89. PubMed ID: 32307338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small dense low density lipoprotein-cholesterol and cholesterol ratios to predict arterial stiffness progression in normotensive subjects over a 5-year period.
    Li G; Wu HK; Wu XW; Cao Z; Tu YC; Ma Y; Wang WQ; Cheng J; Zhou ZH
    Lipids Health Dis; 2018 Feb; 17(1):27. PubMed ID: 29433526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated small dense low-density lipoprotein cholesterol as a predictor for future cardiovascular events in patients with stable coronary artery disease.
    Nishikura T; Koba S; Yokota Y; Hirano T; Tsunoda F; Shoji M; Hamazaki Y; Suzuki H; Itoh Y; Katagiri T; Kobayashi Y
    J Atheroscler Thromb; 2014; 21(8):755-67. PubMed ID: 24717762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small dense low-density lipoprotein-cholesterol (sdLDL-C): Analysis, effects on cardiovascular endpoints and dietary strategies.
    Santos HO; Earnest CP; Tinsley GM; Izidoro LFM; Macedo RCO
    Prog Cardiovasc Dis; 2020; 63(4):503-509. PubMed ID: 32353373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
    Mora S; Caulfield MP; Wohlgemuth J; Chen Z; Superko HR; Rowland CM; Glynn RJ; Ridker PM; Krauss RM
    Circulation; 2015 Dec; 132(23):2220-9. PubMed ID: 26408274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Density Lipoprotein Cholesterol and Adverse Cardiovascular Events After Percutaneous Coronary Intervention.
    Sud M; Han L; Koh M; Abdel-Qadir H; Austin PC; Farkouh ME; Godoy LC; Lawler PR; Udell JA; Wijeysundera HC; Ko DT
    J Am Coll Cardiol; 2020 Sep; 76(12):1440-1450. PubMed ID: 32943162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of C-reactive protein before and on-treatment as a predictor of benefit of atorvastatin: a cohort analysis from the Anglo-Scandinavian Cardiac Outcomes Trial lipid-lowering arm.
    Sever PS; Poulter NR; Chang CL; Thom SA; Hughes AD; Welsh P; Sattar N;
    J Am Coll Cardiol; 2013 Aug; 62(8):717-29. PubMed ID: 23948514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small dense low-density lipoprotein cholesterol is a promising biomarker for secondary prevention in older men with stable coronary artery disease.
    Sakai K; Koba S; Nakamura Y; Yokota Y; Tsunoda F; Shoji M; Itoh Y; Hamazaki Y; Kobayashi Y
    Geriatr Gerontol Int; 2018 Jun; 18(6):965-972. PubMed ID: 29512264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive Association Between Small Dense Low-Density Lipoprotein Cholesterol Concentration and Biomarkers of Inflammation, Thrombosis, and Prediabetes in Non-Diabetic Adults.
    Hsu SH; Jang MH; Torng PL; Su TC
    J Atheroscler Thromb; 2019 Jul; 26(7):624-635. PubMed ID: 30587667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.